[1] Iqbal Z, Azmi S, Yadav R, et al. Diabetic peripheral neuropathy: epidemiology, diagnosis, and pharmacotherapy[J]. Clinical therapeutics, 2018, 40: 828-849. [2] Liu C, Yuan YC, Guo MN, et al. Incidence of type 1 diabetes may be underestimated in the chinese population: evidence from 21.7 million people between 2007 and 2017[J]. Diabetes care, 2021, 44: 2503-2509. [3] Fan T, Yu Y, Chen YL, et al. Histone deacetylase 5-induced deficiency of signal transducer and activator of transcription-3 acetylation contributes to spinal astrocytes degeneration in painful diabetic neuropathy[J]. Glia, 2023, 71: 1099-1119. [4] Bonin RP, Bories C, De Koninck Y. A simplified up-down method (SUDO) for measuring mechanical nociception in rodents using von Frey filaments[J]. Mol Pain, 2014, 10:26; doi:10.1186/1744-8069-10-26. [5] Xu Q, Ford NC, He S, et al. Astrocytes contribute to pain gating in the spinal cord[J]. Science advances, 2021, 7; doi: 10.1126/sciadv.abi6287. [6] Dvoriantchikova G, Barakat D, Brambilla R, et al. Inactivation of astroglial NF-kappa B promotes survival of retinal neurons following ischemic injury[J]. Eur J Neurosci, 2009, 30: 175-185. [7] Hashioka S, Klegeris A, Qing H, et al. STAT3 inhibitors attenuate interferon-γ-induced neurotoxicity and inflammatory molecule production by human astrocytes[J]. Neurobiol Dis, 2011, 41: 299-307. [8] Herrmann JE, Imura T, Song B, et al. STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury[J]. J Neurosci, 2008, 28:7231-7243. [9] Anderson MA, Burda JE, Ren Y, et al. Astrocyte scar formation aids central nervous system axon regeneration[J]. Nature, 2016, 532: 195-200. [10] Tyzack GE, Hall CE, Sibley CR, et al. A neuroprotective astrocyte state is induced by neuronal signal EphB1 but fails in ALS models[J]. Nat Commun, 2017, 8: 1164; doi:10.1038/s41467-017-01283-z. [11] Lan G, Wang P, Chan RB, et al. Astrocytic VEGFA: An essential mediator in blood-brain-barrier disruption in Parkinson′s disease[J]. Glia, 2021, 70: 337-353. |